« FDA Extends Review of Genasense(R) NDA Appeal in Chronic Lymphocytic | Main | FDA Approves Voluven to Treat Serious Blood Volume Loss following »

FDA Clears First Quick Test For Drug-Resistant Staph Infections The


FDA Clears First Quick Test For Drug-Resistant Staph Infections
The U.S. Food and Drug Administration (FDA) today announced it has cleared for marketing the first rapid blood test for the drug-resistant staph bacterium known as MRSA (methicillin-resistant Staphylococcus aureus), which can cause potentially deadly infections.
 

©2006 FDA-News.com. All rights reserved.